List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 18 studies with search of: lymphoma [CONDITION] AND "South Africa" [LOCATION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: RAD001;   Drug: Placebo
2 Active, not recruiting Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
3 Recruiting Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: PXD101
4 Recruiting Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone;   Drug: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
5 Active, not recruiting Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Bortezomib + Rituximab;   Drug: Rituximab
6 Active, not recruiting A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-Cell Lymphoma: NHL-13
Conditions: Diffuse Large B-Cell Lymphoma (DLBCL);   Follicular NHL Grade 3b
Intervention: Drug: Rituximab
7 Active, not recruiting An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)
Condition: Multiple Myeloma or Non-Hodgkin's Lymphoma
Interventions: Drug: bortezomib;   Drug: rifampicin
8 Active, not recruiting Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate
9 Active, not recruiting Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Radiation: yttrium Y 90 ibritumomab tiuxetan
10 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
11 Active, not recruiting Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Radiation: radiation therapy
12 Active, not recruiting Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisolone;   Drug: vincristine sulfate;   Radiation: radiation therapy
13 Active, not recruiting Study Comparing Inotuzumab Ozogamicin in Combination With Rituximab Versus Defined Investigator's Choice in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Follicular
Interventions: Drug: inotuzumab ozogamicin;   Drug: rituximab;   Drug: cyclophosphamide, vincristine and prednisone/prednisolone (R-CVP);   Drug: fludarabine, Novantrone (mitoxantrone) and dexamethasone (R-FND)
14 Completed Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Intervention: Biological: rituximab
15 Active, not recruiting Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Conditions: Myeloid Leukemia, Chronic, Accelerated Phase;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: dasatinib
16 Active, not recruiting Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
Condition: Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Interventions: Drug: Zoledronic Acid;   Biological: Denosumab
17 Active, not recruiting Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
Condition: Gastric Cancer
Interventions: Drug: chlorambucil;   Drug: clarithromycin;   Drug: omeprazole;   Drug: tinidazole
18 Completed Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Condition: Leukemia
Intervention: Drug: arsenic trioxide

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services